S.Amdt. 27Senate118th Congress (2023-2025)
S.Amdt. 27
Sponsored by
Sen. Mike Lee (R-UT)
Submitted March 21, 2023
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
March 21, 2023
View full timeline
Floor
Senate amendment submitted
March 21, 2023
Floor
Senate amendment submitted
March 21, 2023
Text
Submitted
SA 27. Mr. LEE submitted an amendment intended to be proposed by him to the bill S. 316, to repeal the authorizations for use of military force against Iraq; which was ordered to lie on the table; as follows: At the appropriate place, insert the following: SEC. __. EXEMPTIONS FROM FDA REQUIREMENTS WITH RESPECT TO INFANT FORMULA. (a) Waivers.-- (1) In general.--In the case that an infant formula shortage is established through a joint resolution, with respect to any infant formula imported into the United States during the 90-day period beginning on the date specified in such joint resolution-- (A) the requirements under section 412 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a) shall not apply; (B) such infant formula may be manufactured, processed, packed, or held in a facility in a country described in subsection (d) that is not registered under section 415 of such Act (21 U.S.C. 350d); (C) the requirements under parts 106 and 107 of title 21, Code of Federal Regulations, shall not apply; and (D) such infant formula shall not be considered to be misbranded or adulterated solely on the basis of not being in compliance with the requirements of such section 412 or 415, or such part 106 or 107. (2) Renewal of waiver period.--A waiver of requirements under paragraph (1) shall automatically renew for additional 90-day periods until such infant formula shortage is terminated through a subsequent joint resolution. (b) Notification Requirement.-- (1) In general.--A person who introduces or delivers for introduction into interstate commerce an infant formula pursuant to subsection (a) shall notify the Secretary if such person has knowledge which reasonably supports the conclusion that such infant formula-- (A) may not provide the nutrients required by section 412(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(i)); or (B) is a product that meets any criterion under section 402(a) of such Act (21 U.S.C. 342(a)), or which otherwise may be unsafe for infant consumption. (2) Knowledge defined.--For purposes of paragraph (1), the term ``knowledge'' as applied to a person subject to such subparagraph means-- (A) the actual knowledge that the person had; or (B) the knowledge which a reasonable person would have had under like circumstances or which would have been obtained upon the exercise of due care. (c) Recall Authority.--If the Secretary determines that infant formula introduced or delivered for introduction into interstate commerce pursuant to subsection (a) is a product described in subsection (b)(1)(B), the manufacturer or importer shall immediately take all actions necessary to recall shipments of such infant formula from all wholesale and retail establishments, consistent with recall regulations and guidelines issued by the Secretary. (d) Countries Described.--A country described in this subsection is any of the following: (1) Australia. (2) Israel. (3) Japan. (4) New Zealand. (5) Switzerland. (6) South Africa. (7) The United Kingdom. (8) A member country of the European Union. (9) A member country of the European Economic Area. (e) Definition.--In this section, the term ``infant formula'' has the meaning given that term in section 201(z) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(z)). ______